Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1941-1949

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac-Specific Expression of the Hepatocyte Growth Factor (HGF) Under the Control of a TnIc Promoter Confers a Heart Protective Effect After Myocardial Infarction (MI)

By  

Current Gene Therapy, Vol. 14, Iss. 1, 2014-02 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Dual activation of adenosine A 1 and A 3 receptors mediates preconditioning of isolated cardiac myocytes

By Wang J.   Drake L.   Sajjadi F.   Firestein G.S.   Mullane K.M.   Bullough D.A.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 241-248

Elsevier

Access to resources Recommend Favorite

Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-01 ,pp. : 1305-1310

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel, Biodegradable, Thermoresponsive Hydrogel Attenuates Ventricular Remodeling and Improves Cardiac Function Following Myocardial Infarction - a review

By  

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 2040-2047

Bentham Science Publishers

Access to resources Recommend Favorite